Inventor · disambiguated record
Michael L. Lacroix-Fralish
Also filed as: LACROIX-FRALISH MICHAEL L · LaCroix-Fralish Michael
13 granted patents·8 pending applications·46 citations·filing 2010–2024
88Inventor score
Top patents by PatentIndex Score
21 records- 0190US8425907B2Methods for treating pruritus by administering an antibody that specifically binds human PAR2MACDONALD LYNN·Filed 2011·Granted Apr 23, 2013·14 cites·6 claims
- 0287US8486647B2Neuropeptide release assay for sodium channelsALESSANDRI HABER NICOLE M·Filed 2011·Granted Jul 16, 2013·15 cites·27 claims
- 0387US8101724B2High-affinity human antibodies to human protease-activated receptor-2MACDONALD LYNN·Filed 2010·Granted Jan 24, 2012·10 cites·6 claims
- 0474US10285388B2Non-human animals having a disruption in a C9ORF72 locusREGENERON PHARMA·Filed 2016·Granted May 14, 2019·2 cites·30 claims
- 0572US9371383B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2013·Granted Jun 21, 2016·1 cites·16 claims
- 0672US8871996B2Mice expressing human voltage-gated sodium channelsMACDONALD LYNN·Filed 2011·Granted Oct 28, 2014·3 cites·23 claims
- 0771US9028819B2Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2REGENERON PHARMA·Filed 2013·Granted May 12, 2015·1 cites·26 claims
- 0869US2021392865A1Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perceptionREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0964US11547101B2Non-human animals having a disruption in a C9ORF72 locusREGENERON PHARMA·Filed 2019·Granted Jan 10, 2023·0 cites·8 claims
- 1063US2019261610A1Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perceptionREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 1160US2020370054A1Non-human animals having a hexanucleotide repeat expansion in a c9orf72 locusREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1259US10513557B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2017·Granted Dec 24, 2019·0 cites·27 claims
- 1357US12161636B2Method of increasing lifespan in mammalsCELLULAR LONGEVITY INC·Filed 2024·Granted Dec 10, 2024·0 cites·25 claims
- 1457US9150648B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2013·Granted Oct 6, 2015·0 cites·19 claims
- 1556US2014134189A1Anti-prokineticin receptor (prokr) antibodies and uses thereofREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 1655US10285387B2Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perceptionREGENERON PHARMA·Filed 2016·Granted May 14, 2019·0 cites·21 claims
- 1755US2018208656A1Anti-Prokineticin Receptor (PROKR) Antibodies and Uses ThereofREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 1852US9951132B2Anti-prokineticin receptor (PROKR) antibodies and uses thereofREGENERON PHARMA·Filed 2015·Granted Apr 24, 2018·0 cites·14 claims
- 1952US2025170113A1Method of increasing lifespan in mammalsCELLULAR LONGEVITY INC·Filed 2024·Application pending·0 cites
- 2047US2016002332A1Anti-ASIC1 Antibodies and Uses ThereofREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 2146US2024033327A1Lnp and liposome compositions for longevity in mammals and methods of using the sameCELLULAR LONGEVITY INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael L. Lacroix-Fralish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →